Moderna, Inc. — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-02-14

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-12	Common Stock	S	5000	$19.44	Disposed	2071530	Direct
2020-02-13	Common Stock	S	5000	$19.23	Disposed	2066530	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.25 to $19.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.90 to $19.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.